Swissport The Netherlands has been awarded the International Air Transport Association’s (IATA) CEIV Pharma certificate at Amsterdam Airport Schiphol.
The cargo handler says the certification reflects Swissport’s “dedication to offer excellent life science & healthcare shipment handling services” and will increase its contribution to the Pharma Gateway Amsterdam.
The subsidiary of Swissport International says the flow of life science & healthcare shipments has been increasing over the past few years, so maintaining a stable and secure supply chain requires specific equipment, storage facilities, harmonised handling procedures and above all, strong cooperation among cool chain partners.
Swissport The Netherlands started to develop a dedicated product line for handling of life science & healthcare shipments and with the recent acquisition of Terminal 9, the scope for this product line was broadened and today, all of Swissport’s operational activities in the Netherlands (both Terminal 9 and 11) have been successfully awarded IATA’s CEIV Pharma certification.
Swissport The Netherlands director of cargo, Jeroen Giling says: “The certificate is a validation of the hard work that our team put in the pharma product. But that is not where we stop. In cooperation with our valued customers, we believe that the pharma product is a product line with continuous improvement cycles.
“This means that we will keep investing in training our staff, maintaining the best controlled pharma facilities and further develop procedures to ensure a secure and high quality pharma chain.”
